生物医药

病毒免疫机制与疫苗佐剂研发
抗病毒药物筛选及分子机制研究

1. Dong, X., Li, B., Yu, B., Chen, T., Hu, Q.,* Peng, B., Sheng, W.: Poria cocos polysaccharide induced Th1-type immune responses to ovalbumin in mice. Plos One. 16, e0245207 (2021).
2. Xia, Y., Deng, X., Cao, M., Liu, S., Zhang, X., Xiao, X., Shen, S., Hu, Q., * Sheng, W.: Nanodiamond-based layer-by-layer nanohybrids mediate targeted delivery of miR-34a for triple negative breast cancer therapy. Rsc Adv. 8, 13789–13797 (2018).
3. Li, B., Shen, S., Zhang, W., Qi, T., Hu, Q., * Cheng, Y.: Long Non-Coding RNA TUG1 as a Potential Novel Biomarker for Predicting the Clinical Outcome of Cancer Patients: a Meta-Analysis. Clinical Laboratory. 64, 180520 (2018).
4. Wang, X., Wang, J., Zhang, W., Li, B., Zhu, Y., Hu, Q., * Yang, Y., Zhang, X., Yan, H., Zeng, Y.: Inhibition of Human Immunodeficiency Virus Type 1 Entry by a Keggin Polyoxometalate. Viruses. 10, 265 (2018).
5. Deng, X., Yin, Z., Lu, J., Li, X., Shao, L., Zhao, C., Yang, Y., Hu, Q., * Wu, Y., Sheng, W.: In Situ Monitoring of MicroRNA Replacement Efficacy and Accurate Imaging‐Guided Cancer Therapy through Light‐Up Inter‐Polyelectrolyte Nanocomplexes. Advanced Science. 5, 1700542 (2018).

2018-2020 北京市自然科学基金面上基金（7182012）
2014-2016 北京市自然科学基金面上基金（7142013）
2013-2015国家自然科学基金青年基金(81202976)